Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             86 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acute liver failure secondary to co-infection of Hepatitis B and HIV Estevez-López, Yajzeel

29 S2 p.
artikel
2 Association of IFNL3 gene rs4803217 with spontaneous clearance of Hepatitis C virus in patients from West Mexico Ochoa-Cervantes, Andrea Y.

29 S2 p.
artikel
3 Bouveret syndrome, a rare clinical presentation of abdominal pain in a patient with diabetic ketoacidosis: A case report. Montes-Castellanos, Camila

29 S2 p.
artikel
4 Bovine matrix scaffold implanted in rat liver improve regeneration in a partial hepatectomy model. Martinez-Castillo, Moises

29 S2 p.
artikel
5 BUN/creatinine ratio associated with mortality in patients with cirrhosis and acute kidney injury. Abendaño-Rivera, Diego F.

29 S2 p.
artikel
6 Characteristics and outcome of patients with liver abscess, a retrospective cohort. Alegría-Ovando, María C.

29 S2 p.
artikel
7 Characteristics of patients with overlap syndrome of autoimmune liver diseases in a third level hospital. Cobos-Quevedo, Orestes J.

29 S2 p.
artikel
8 Chronic liver damage in hemodialysis users. The importance of molecular tests for detection of hidden infection by hepatotropic viruses in high-risk groups Rodríguez-Campos, Arlette

29 S2 p.
artikel
9 CLIF-C-ACLF scale to predict mortality in pediatric patients with acute-on-chronic liver failure Arellano-Sánchez, Diego R.

29 S2 p.
artikel
10 Clinical and epidemiological characterization of patients with hepatocarcinoma Cruz-Rodríguez, Lissa M.

29 S2 p.
artikel
11 Clinical characteristics, therapeutic approach, and outcomes in patients with hepatocellular carcinoma at a third-level hospital. Cupil-Escobedo, Laura V.

29 S2 p.
artikel
12 Collagen matrix scaffold as vehicle of WP1066, STAT-3 inhibitors, in an in vitro hepatocellular model. Martinez-Castillo, Moises

29 S2 p.
artikel
13 Comparison of non-invasive scores for the evaluation of liver fibrosis in subjects with metabolic dysfunction-associated fatty liver disease (MAFLD) Priego-Parra, Bryan A.

29 S2 p.
artikel
14 Correlation between steatosis and fibrosis in patients with metabolic syndrome Juárez-Chavez, Leonardo S.

29 S2 p.
artikel
15 Demographic and clinical characteristics of patients with chronic HCV infection in a third-level IMSS Hospital in Mexico City Torres-Castro, Areli

29 S2 p.
artikel
16 Detecting the risk for fatty liver, MASH, and insulin resistance using different indexes and markers of liver damage in young adults from West Mexico Leal-Mercado, Leonardo

29 S2 p.
artikel
17 Development of hepatic steatosis in liver transplant recipient patients. Carrillo-Rojas, Javier I.

29 S2 p.
artikel
18 EDITORIAL BOARD
29 S2 p.
artikel
19 Effect of methyl donor supplementation on gut microbiota and hepatic expression of key miRNAs in a murine model of MAFLD Rosas-Campos, Rebeca

29 S2 p.
artikel
20 Effect of the combination of orlistat and l-carnitine on the quality of life (sf-36) in 16 overweigth patients. a preliminary result Vera-Nungaray, Saúl A.

29 S2 p.
artikel
21 Efficacy and safety of intravenous L-ornithine L-aspartate in patients with grade III and IV hepatic encephalopathy Rangel-Zavala, Gabriela

29 S2 p.
artikel
22 Endoscopic ultrasound guided portal pressure gradient: safety aspects, clinical relevance and technical issues to improve the procedure Romero-Castro, Rafael

29 S2 p.
artikel
23 Epidemiological changes in the incidence of acute liver failure at a hospital in Mexico City Guirao-Pérez, Rodrigo

29 S2 p.
artikel
24 Epidemiology and demographic aspects in patients with acute on chronic liver failure in a third-level care hospital in Mexico. Zafra-Hernandez, Guadalupe

29 S2 p.
artikel
25 Evaluation of severity and survival scales in acute-on-chronic liver failure(ACLF) in a Mexican population sample. Teutli-Carrión, Sandra

29 S2 p.
artikel
26 Evaluation of the ALBI, MELD, MELD-Na, MELD 3.0 score in patients with hepatocellular carcinoma treated with Yttrium-90 (90y) Cornejo-Hernandez, Stefanny

29 S2 p.
artikel
27 Evaluation of the effect of Cinnamomum cassia oil on markers of oxidative stress and its modification in gene expression in a diabetic rat model induced with alloxane. Hernández-Cruz, Flor E.

29 S2 p.
artikel
28 Evaluation of the hepatoprotective effect of an hydroalcoholic extract of Jatropha dioica against the damage induced by valproic acid in Wistar rats Tijerina-Márquez, Ramiro

29 S2 p.
artikel
29 Evaluation of the hepatoprotective effect of Flourensia cernua against the damage induced ischemia-reperfusion in Wistar rats. García-Carmona, Evelyn L.

29 S2 p.
artikel
30 Evaluation of the MELNa AGIB Scale to Predict Mortality in Patients with Cirrhosis and Variceal Hemorrhage. Carmona-Castillo, Miguel Y.

29 S2 p.
artikel
31 Exploring the metabolic and molecular benefits of methyl donor supplementation in a model of metabolic and fatty liver disease Vazquez-Esqueda, Angel

29 S2 p.
artikel
32 “Explosive” worsening of chronic hepatitis C-associated cryoglobulinemia vasculitis, as unmasking of lymphoma a case report. Olivo-Saldaña, Mara S.

29 S2 p.
artikel
33 Extrahepatic disease in a cohort of HCV infected patients succesfully treated with direct acting antivirals. One year follow up. Sánchez-Rodríguez, Clara C.

29 S2 p.
artikel
34 Factors associated with mortality in patients with cirrhosis. Cazarin-Chávez, Karina

29 S2 p.
artikel
35 Frailty and diet quality index in patients with chronic HCV infection with and without cirrhosis. Preliminary report Vázquez-Rodríguez, Daniela

29 S2 p.
artikel
36 From Hepatitis E to Autoimmune Hepatitis: Aftermath of a trip to Qatar Duran-Azamar, Pamela

29 S2 p.
artikel
37 Hepatic injury biomarkers in COVID-19 Tapia-Calderón, Diana K.

29 S2 p.
artikel
38 Hepatic Steatosis Index (HSI): A Valuable Biomarker in Subjects with Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) Priego-Parra, Bryan A.

29 S2 p.
artikel
39 Hepatitis A at the Hospital de Especialidades Centro Medico Nacional La Raza. Preliminary report. Garcia-Campos, Karenn

29 S2 p.
artikel
40 Hepatitis C virus-infected patients carriers of the TT (C*52T, rs14158) genotype of the LDL receptor and Apo3 present severe liver damage in West Mexico Campos-Medina, Liliana

29 S2 p.
artikel
41 Hepatitis C Virus NS5A and Core protein induce hepatic stellate cells activation promoting fibrosis-related gene regulation on hepatocytes. Heredia-Torres, Tania G.

29 S2 p.
artikel
42 Hepatitis secondary to consumption of piñalim Moranchel–García, Leslie

29 S2 p.
artikel
43 Hepatocellular carcinoma and upper gastrointestinal bleeding Ortega-García, Ricardo J.

29 S2 p.
artikel
44 Hepatocellular carcinoma with metastasis to the inferior cava vein and right atrium, an unusual cause of Budd Chiari Syndrome Tadeo-Jiménez, Yvonne

29 S2 p.
artikel
45 Hepatology at the Civil Hospital of Guadalajara, Fray Antonio Alcalde (HCGFAA) in the last 25 years and its international scientific productivity Mariscal-Martinez, Irene M.

29 S2 p.
artikel
46 Hepatoprotective effects of N-acetylcysteine prevents hepatocellular carcinoma development induced experimentally. Caloca-Camarena, Fernando

29 S2 p.
artikel
47 25-hydroxyvitamin D deficiency as a factor associated with the development of Hepatic Encephalopathy in the Mexican population. Diego-Salazar, Paloma

29 S2 p.
artikel
48 IGFBP2: a possible molecular link between liver, heart, and bloodstream during metabolic dysfunction-associated steatotic liver disease Bautista-Ubaldo, Miriam G.

29 S2 p.
artikel
49 Impact of cholemic nephrosis on renal failure in cirrhotic patients Lozada-Calle, Silvia J.

29 S2 p.
artikel
50 Impact of spontaneous bacterial peritonitis on the outcome of patients with cirrhosis Teutli-Carrión, Sandra

29 S2 p.
artikel
51 Incidence and Associated factors to development of hyponatremia in a cohort of ambulatory patients with compensated liver cirrhosis López-Sánchez, Marlene

29 S2 p.
artikel
52 Intrahepatic Cholestasis Induced by Leflunomide: An Unusual Presentation of DILI Martínez-Pérez, Genesis P.

29 S2 p.
artikel
53 In vitro analysis of apoptosis in hepatic stellate cells cultured under steatogenic conditions Campos-Espinosa, Adriana

29 S2 p.
artikel
54 Lactate-albumin ratio as a predictor of mortality in patients with acute on chronic liver failure in a third-level care hospital in Mexico Zafra-Hernández, Guadalupe

29 S2 p.
artikel
55 Levels of IGFBP-1, 3 and 7 in human serum induced by alcohol consumption, NAFLD and dual insult Hernandez-Barragan, Abigail

29 S2 p.
artikel
56 LILLE-4 vs. LILLE-7 to predict short-term mortality in patients with severe alcoholic hepatitis Dorantes-Nava, Claudia L.

29 S2 p.
artikel
57 Metabolic dysfunction-associated fatty liver disease in overweight and obese pediatric population: clinical and biochemical characterization Lescas-Orozco, Marion

29 S2 p.
artikel
58 Methyl-group donor supplementation beneficial effects on metabolic, histological, and inflammatory parameters in a murine model of alcoholic steatohepatitis Diaz-Canul, Carolina

29 S2 p.
artikel
59 METS-IR and its correlation with the diagnosis of nonalcoholic fatty liver disease corroborated by elastography. Hernández-Ortega, María E.

29 S2 p.
artikel
60 MexMix supplementation prevented MAFLD development by restoring microbiota-gut-liver axis in a mice model. Rosas-Campos, Rebeca

29 S2 p.
artikel
61 N-acetyl cysteine prevents alterations generated during experimental liver steatosis induced by a chronic consumption of alcohol plus a hypercaloric diet. Galicia-Moreno, Marina

29 S2 p.
artikel
62 Neutrophil/Lymphocyte ratio in patients with spontaneous bacterial peritonitis. Sánchez-Salinas, Francisco

29 S2 p.
artikel
63 Noninvasive markers of hepatic fibrosis and their clinical application in coronary artery disease. Velasco, José A. Velarde-Ruiz

29 S2 p.
artikel
64 Observational Study of Biliary Duct stenosis in patients with Post-Liver Transplant Sosa-Martinez, Raul

29 S2 p.
artikel
65 One-year survival after liver transplantation in a group of geriatric patients Tinitana-Jumbo, Carlos S.

29 S2 p.
artikel
66 Overlap syndrome: Report of a case and review of the literature. Méndez-Verdejo, Karent I.

29 S2 p.
artikel
67 Passenger lymphocyte syndrome, an unusual cause of anemia after liver transplantation Gutierrez-Castillo, Alejandro

29 S2 p.
artikel
68 Pirfenidone decreases insulin, glucagon, leptin, plasminogen activator inhibitor 1, preventing nonalcoholic steatohepatitis and myocarditis in an obesity moldel López-Cifuentes, Daniel

29 S2 p.
artikel
69 Pirfenidone induces translocation of sirt1 to nucleus and deacetylation of histone 3 slows down the development of fibrosis and tumorigenicity in a experimental model of hepatocarcinoma. Monroy-Ramírez, Hugo C.

29 S2 p.
artikel
70 Pirfenidone slows the development of fibrosis and malignant neoplasms by modulating inflammation in an experimental model of hepatocarcinoma. Arceo-Orozco, Scarlet

29 S2 p.
artikel
71 Poor correlation between HOMA index and Triglycerides/HDL-C ratio as markers of insulin resistance in adult patients with MAFLD. Ramírez-Velázquez, Irlanda A.

29 S2 p.
artikel
72 Prevalence of Immunoglobulin G against Hepatitis A Virus and Hepatitis E Virus in healthcare personnel Garay-Ortega, Jorge A.

29 S2 p.
artikel
73 Prevalence of pregnancy liver diseases in patients at National Medical Center “La Raza” IMSS. Torres-Castro, Areli

29 S2 p.
artikel
74 Primary Hepatic Leiomyosarcoma (PHL) with pulmonary metastatic activity. Case report and literature review Munguía-Guízar, Monserrat M.

29 S2 p.
artikel
75 Prolonged-release pirfenidone in patients with compensated cirrhosis. Final results of the multicenter study ODISEA, controlled against placebo, plus standardized care_2023 Munoz-Espinosa, Linda E.

29 S2 p.
artikel
76 Rapidly progressive glomerulopathy in a patient with hepatitis C virus not diagnosed. Case Report. Galindo-Contreras, Oscar G.

29 S2 p.
artikel
77 Regulation of TGF-β1, 2, and 3 and IL-10 at systemic level in chronic liver disease Hernandez-Santillan, Marisela

29 S2 p.
artikel
78 Retreatment experience with Glecaprevir/Pibrentasvir (G/P) for hepatitis C infection in patients failing first-line direct-acting antiviral agents. Cobos-Quevedo, Orestes J.

29 S2 p.
artikel
79 Secondary Attack Rate of Hepatitis C Virus (HCV) Cisneros-Rodríguez, José A.

29 S2 p.
artikel
80 Segmental portal hypertension secondary to chronic pancreatitis Correa-Cedeño, Karla

29 S2 p.
artikel
81 Survival of patients with hepatocellular carcinoma treated with immunotherapy experience of a third level center. Cornejo-Hernandez, Stefanny

29 S2 p.
artikel
82 Sword of Damocles: a hard blow from hepatitis A. Galván-Rodríguez, Jerónimo D.

29 S2 p.
artikel
83 The role of cirrhosis etiology in the development of acute kidney injury and death Sánchez-Sánchez, Cristian Y.

29 S2 p.
artikel
84 The use of molecular adsorbent recirculating system and single-pass albumin dialysis as liver support: The experience of the Centro Medico Nacional 20 de Noviembre Sosa-Martinez, Raul

29 S2 p.
artikel
85 Utility of the MELD and MELD-Lactate scale in patients with severe Alcoholic Hepatitis as a predictor of severity and early mortality. García-Juárez, Francisco I.

29 S2 p.
artikel
86 Validation of S-ANT for the diagnosis of minimal hepatic encephalopathy Santana-Vargas, Ángel D.

29 S2 p.
artikel
                             86 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland